NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Intact MET Immunoassay   Add to my SOP compendium

BRD ID: 2,246

Source: DCTD Tier: SOP Number of times downloaded: 630

Description

This document describes quantification of MET levels in lysates of frozen needle tumor biopsies using the Intact MET Immunoassay. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Visit the DCTD website (https://dctd.cancer.gov/ResearchResources/biomarkers/Intact_PhosphoMET.htm) for recent updates to the SOP.

Documents for Download

SOP341203_Intact_METIA.pdf [Size: 389 KB]
Biospecimens
  • Tissue - General
Diagnoses
  • Neoplastic - Not specified
  • General
Topics
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • Just Published!
  • April 24, 2024: Biobanking for Precision Medicine Seminar
  • Most Popular SOPs in March 2024
    • More...